Found 68 articles for: "minoxidil"
Highlighting the Link Between Lichen Planus Pigmentosus and Frontal Fibrosing Alopecia
March 2024 | Volume 23 | Issue 3 | Features | 196 | Copyright © March 2024
Efficacy of Low-Dose Spironolactone for Hair Loss in Women
March 2024 | Volume 23 | Issue 3 | Editorials | e91 | Copyright © March 2024
Safety and Efficacy of Minoxidil Treatment in Scarring Alopecia: A Scoping Review
March 2024 | Volume 23 | Issue 3 | Original Article | 146 | Copyright © March 2024
Background: Topical minoxidil (TM) has been a cornerstone in treating various hair loss disorders, while low-dose oral minoxidil (LDOM) is emerging as an effective alternative. D...
Read MoreSurvey of the Prices of Topical Compounded Medications for Alopecia in the Tri-State Area
March 2024 | Volume 23 | Issue 3 | Original Article | 168 | Copyright © March 2024
Background: Currently, there is only one topical medication approved by the U.S. Food and Drug Administration for alopecia, minoxidil 2.5% and 5%. With limited options, dermatolo...
Read MoreSurvey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia
March 2024 | Volume 23 | Issue 3 | Original Article | 136 | Copyright © March 2024
Background: Utilization of low-dose oral minoxidil has increased in recent years in association with several clinical studies that have shown its efficacy in treating androgeneti...
Read MoreOral Minoxidil Media Coverage: The Impact on Patient Perceptions and Practitioner Approaches to Androgenetic Alopecia
January 2024 | Volume 23 | Issue 1 | Editorials | 1364 | Copyright © January 2024
Platelet-Rich Plasma Across the Spectrum of Alopecias: Where Are We Now?
November 2023 | Volume 22 | Issue 11 | Features | 1134 | Copyright © November 2023
The Potential Impact of Off-Label Medication Use on Patient Access: A Cross-Sectional Survey of Minoxidil Availability
January 2024 | Volume 23 | Issue 1 | Editorials | 1360 | Copyright © January 2024
Alopecia Areata: The Clinician and Patient Voice
October 2023 | Volume 22 | Issue 10 | Original Article | 967 | Copyright © October 2023
Alopecia areata (AA), an autoimmune disorder of hair follicles, results in varying degrees of scalp, facial, and body hair loss. In addition, it is associated with profound psychosocial and quali...
Read MoreA Randomized Control Trial Comparing the Efficacy of Platelet-Rich Plasma and 5% Topical Minoxidil for the Treatment of Androgenetic Alopecia
September 2023 | Volume 22 | Issue 9 | Original Article | 905 | Copyright © September 2023
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and has limited treatment options. Minoxidil is a common therapeutic option for AGA patients because of its availability. Plate...
Read MoreReview of Superficial Cryotherapy for the Treatment of Alopecia Areata
August 2023 | Volume 22 | Issue 8 | Original Article | 802 | Copyright © August 2023
Cryotherapy has recently been examined as a potential treatment for alopecia areata (AA). AA is classically managed with intralesional or systemic steroids but relapse rates among those with long...
Read MoreMinimizing Bias in Alopecia Diagnosis in Skin of Color Patients
July 2023 | Volume 22 | Issue 7 | Features | 703 | Copyright © July 2023
Alopecia is one of the most common dermatologic conditions affecting black patients, with a significantly negative impact on quality of life.1,2 Timely and accurate diagnosis is theref...
Read MoreReal-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia
June 2023 | Volume 22 | Issue 6 | Original Article | 559 | Copyright © June 2023
Pattern-type hair loss is a highly prevalent condition affecting the majority of men and women at some point in their lifetime. Although genetics and androgens are instrumental in the pathogenesi...
Read MoreDupilumab Induced Hair Regrowth in Alopecia Totalis
April 2023 | Volume 22 | Issue 4 | Case Reports | 410 | Copyright © April 2023
Alopecia Areata (AA) is an autoimmune process that results in varying degrees of hair loss. Currently, there is no single treatment that has proven to be efficacious in a large cohort of patients...
Read MoreTopical Minoxidil Adherence in Patients With Alopecia
March 2023 | Volume 22 | Issue 3 | Original Article | 252 | Copyright © March 2023
Background: Non-adherence to topical minoxidil in alopecia patients is a barrier to efficacy. Understanding patient factors associated with adherence and non-adherence may provide act...
Read MoreGraham-Little-Piccardi-Lasseur Syndrome: A Case Report
February 2023 | Volume 22 | Issue 2 | Case Reports | 210 | Copyright © February 2023
Graham-Little Piccardi-Lasseur syndrome is a rare dermatosis that affects the hair follicles throughout the body and often presents with a progressive cicatricial alopecia of the scalp that is unrespo...
Read MoreExamining the Potential for Koebnerization and Disease Precipitation in Cicatricial Alopecias
January 2023 | Volume 22 | Issue 1 | Original Article | 29 | Copyright © January 2023
The treatment of primary scarring alopecias is challenging and patients may be susceptible to koebnerization. This predisposes cicatricial alopecia patients to worsening of their disease following pro...
Read MoreRefractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy
December 2022 | Volume 21 | Issue 12 | Case Reports | 1366 | Copyright © December 2022
Background: In the last several years, oral tofacitinib has become an increasingly utilized off-label treatment option for immune-mediated skin conditions such as alopecia areata (AA)...
Read MoreEvaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic Alopecia
November 2022 | Volume 21 | Issue 11 | Original Article | 1166 | Copyright © November 2022
Androgenetic alopecia (AGA) in men and women is the most common cause of hair loss. Affected individuals may experience psychological distress and social withdrawal. Current treatment options for AGA,...
Read MoreThe Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review
October 2022 | Volume 21 | Issue 10 | Original Article | 1070 | Copyright © October 2022
Background: Approximately 30% to 40% of alopecia areata (AA) patients have atopic dermatitis. Studies suggest that antihistamines and dupilumab may be effective treatments; however, t...
Read MoreMedia and other results for: "minoxidil"